Search WGS
GeneDx Holdings Corp.
Nasdaq · CIK 1818331
Last close73.09
Daily change+2.13 (3.00%)
10 Years gain-77.40%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
WGS · STANDARD
SIC 8000 · Services-Health Services · Fiscal year end 1231
Fundamental
57.3Momentum
32.2Acceleration
32.2Confidence
77.0Annual Revenue7
Quarterly Revenue25
Annual CFO7
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth22.8 / 25
Quality18.7 / 25
Capital Efficiency0.0 / 20
Balance Sheet13.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 6.3505 percentage points.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Operating margin compression · MEDIUMOperating margin compressed by 3.5545 percentage points.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM46.88%OK
Revenue CAGR 3Y22.13%OK
Gross Margin69.22%OK
Operating Margin-15.87%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-29.93%OK
Incremental Operating Margin 3Y297.09%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y5.55%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $427.54M | $298.17M | -$13.08M | $33.28M | $14.26M | 69.74% | -3.06% | 3.34% | -5.88% | 28.64M |
| 2025 FY Dec 31, 2024 | $305.45M | $194.40M | -$23.21M | -$28.50M | -$33.99M | 63.64% | -7.6% | -11.13% | -11.68% | 26.89M |
| 2025 FY Dec 31, 2023 | $202.57M | $90.01M | -$180.60M | -$180.15M | -$185.40M | 44.43% | -89.15% | -91.52% | -96.76% | 24.31M |
| 2023 FY Dec 31, 2022 | $234.69M | -$26.75M | -$667.65M | -$319.16M | -$326.31M | -11.4% | -284.48% | -139.04% | -757.25% | 10.24M |
| 2022 FY Dec 31, 2021 | $212.20M | -$16.60M | -$446.15M | -$190.43M | -$199.83M | -7.82% | -210.25% | -94.17% | n/a | 108.08M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $436.13M | sum latest 4 fiscal quarters Revenue | OK | 0001628280-26-051878, 0001818331-25-000130 |
| Revenue Growth TTM | 46.88% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-26-051878, 0001818331-25-000130 |
| Revenue CAGR 3Y | 22.13% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001818331-26-000015 |
| Revenue CAGR 5Y | 18.98% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001818331-26-000015 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001818331-26-000015 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001628280-26-051878, 0001818331-25-000130 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 69.22% | Gross Profit / Revenue | OK | 0001628280-26-051878, 0001818331-25-000130 |
| Operating Margin | -15.87% | Operating Income / Revenue | OK | 0001628280-26-051878, 0001818331-25-000130 |
| ROIC | -29.93% | NOPAT / Average Invested Capital | OK | 0001628280-26-051878, 0001818331-25-000130 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001628280-26-051878 |
| Current Ratio | 3.3x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 1.33x | (Cash + Short-term Investments) / Total Debt | OK | 0001628280-26-051878 |
| Revenue per Diluted Share | $14.68 | Revenue / Diluted Shares | OK | 0001628280-26-051878, 0001818331-25-000130 |